Gilead Sciences: Cholangitis trials
The registry lists 11 Cholangitis studies with Gilead Sciences as lead sponsor. 0 are open to participants now and 10 have results posted.
Phase 1 2Phase 2 5Phase 3 3No phase 1(a study in two phases counts in both)
Studies
Open to participants first, then studies with results posted, then the rest; newest registration first within each.
- RESPONSE: Response to Seladelpar in Subjects With Primary Biliary Cholangitis (PBC) and an Inadequate Control to or an Intolerance to Ursodeoxycholic Acid (UDCA)CompletedNCT04620733Phase 3Results posted
- Safety and Tolerability of Cilofexor in Participants With Primary Sclerosing Cholangitis (PSC) and Compensated CirrhosisTerminatedNCT04060147Phase 1Results posted
- A Study to Evaluate the Safety, and Tolerability, and Efficacy of Seladelpar in Patients With PSCTerminatedNCT04024813Phase 2Results posted
- Study of Cilofexor in Adults With Primary Sclerosing CholangitisTerminatedNCT03890120Phase 3Results posted
- ENHANCE: Seladelpar in Subjects With Primary Biliary Cholangitis (PBC) and an Inadequate Response to or an Intolerance to Ursodeoxycholic Acid (UDCA)CompletedNCT03602560Phase 3Results posted
- Seladelpar (MBX-8025) in Subjects With Primary Biliary Cholangitis (PBC)CompletedNCT02955602Phase 2Results posted
- Study to Evaluate the Safety, Tolerability, and Efficacy of Cilofexor in Adults With Primary Sclerosing Cholangitis Without CirrhosisCompletedNCT02943460Phase 2Results posted
- Study to Evaluate the Safety, Tolerability, and Efficacy of Cilofexor in Adults With Primary Biliary Cholangitis Without CirrhosisTerminatedNCT02943447Phase 2Results posted
- Pharmacokinetics and Pharmacodynamics of Cilofexor in Adults With Normal and Impaired Hepatic FunctionCompletedNCT02808312Phase 1Results posted
- Simtuzumab (GS-6624) in the Prevention of Progression of Liver Fibrosis in Adults With Primary Sclerosing Cholangitis (PSC)CompletedNCT01672853Phase 2Results posted
- Development of a Patient-Reported Outcome Measure to Assess Symptoms in Patients With Primary Sclerosing Cholangitis (PSC)CompletedNCT02247934